![](https://ml.globenewswire.com/media/51670c91-d369-4a8c-8102-d393de9f6d19/small/download-jpg.jpg)
Eagle Pharmaceuticals (EGRX) Shares Crash After CEO Tarriff Resigns and Disclosing Non-Compliance with Nasdaq - Hagens Berman
SAN FRANCISCO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) investors who suffered substantial losses to submit your losses now. Eagle Pharmaceuticals, Inc. (EGRX) Investigation: “The investigation …